Search for: "PFIZER PHARMACEUTICALS LLC"
Results 121 - 140
of 159
Sorted by Relevance
|
Sort by Date
18 Jan 2013, 2:06 pm
The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
17 Oct 2013, 5:00 am
Mutual Pharmaceutical Co., 731 F. [read post]
15 May 2009, 1:03 am
Pfizer Again Beats Back Class Certification Motion in Consumer Fraud Case
The American Lawyer
Shortly after Pfizer predecessor Warner-Lambert agreed to pay more than $430 million to resolve criminal charges and civil liabilities for promoting off-label uses for its epilepsy drug Neurontin in 2004, plaintiffs lawyers sought to represent a nationwide class of consumers and third-party payers against the pharmaceutical giant, demanding more than $4… [read post]
18 Jul 2014, 11:55 am
Pfizer, Inc., 716 F.3d 1087, 1092-93 (8th Cir. 2013). [read post]
2 Feb 2018, 4:00 am
Valeant Pharmaceuticals International Inc. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
11 Nov 2010, 12:54 pm
Pfizer Inc., 2009 WL 3230611, at *8 (W.D. [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
11 Jul 2008, 4:30 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
29 Dec 2011, 6:53 am
Wyeth LLC, 131 S. [read post]
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]
1 May 2024, 1:18 pm
Kan Di Ki LLC, the U.S. [read post]
3 Sep 2009, 1:24 am
Ropes & Gray Leads on Pfizer's Record $2.3 Billion Settlement
The American Lawyer
Ropes & Gray took the lead among several firms in advising Pfizer on its decision Wednesday to pay $2.3 billion in fines and penalties to settle charges it illegally marketed several drugs for off-label uses and paid kickbacks to doctors, according to lawyers on the deal. [read post]
27 Mar 2018, 4:00 am
More recently, in Seedlings Life Science Ventures, LLC v. [read post]
4 Nov 2021, 7:03 pm
This trend is particularly evident in the pharmaceutical sector, where violations of the FCA have forced corporate behemoths like GlaxoSmithKline and Pfizer into billion-dollar settlements. [read post]
1 Jan 2019, 5:10 pm
In addition, the drug manufacturer Pfizer paid approximately $23.85 million to resolve claims that it used a foundation as a conduit to pay the co-pays of Medicare patients taking Pfizer drugs. [read post]
8 Oct 2008, 11:50 am
Allergan Pharmaceuticals, Inc., 400 So.2d 820, 823 (Fla. [read post]
31 Dec 2014, 5:00 am
Xanodyne Pharmaceuticals, Inc., 771 F.3d 1218 (9th Cir. 2014) (en banc). [read post]
22 Mar 2008, 2:00 am
: (Generic Pharmaceuticals & IP),EU: Counterfeit medicines in the EU: a new consultation: (Class 46)Thailand US Trade Representative to ‘talk’ to Thai government: (Generic Pharmaceuticals & IP), US: Cellectis SA files suit against Precision BioSciences, alleging infringement of two patents relating to materials used to make genome modifications in certain types of organisms: (IP Law360), US: PharmaBiotech IP Summit 28-30 May, Philadelphia will… [read post]
